全球臍帶血庫市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

預計臍帶血庫市場將從 2025 年的 340 億美元成長到 2034 年的 670.7 億美元，2026 年至 2034 年的複合年成長率為 7.84%。

隨著細胞療法和再生醫學的應用範圍從血液學領域擴展到更廣泛的免疫療法和組織修復領域，臍帶血庫正步入發展階段。臍帶血富含造血幹細胞和前驅細胞，可用於移植醫學，並作為基因工程免疫細胞和再​​生醫學構建體等細胞治療方法的新型儲存庫而備受關注。隨著從自體免疫疾病到新生兒腦損傷等新適應症在臨床試驗中得到證實，對高品質冷凍保存的臍帶血及其相關生物銀行服務的需求將持續成長。策略差異化將取決於臍帶血的品質、處理方法以及提供相關臨床數據的能力，從而增強其臨床應用價值。

工藝創新和標準化是獲得競爭優勢的關鍵。封閉式自動化收穫和處理平台可降低污染風險並提高活細胞產量。標準化的活力測量、療效指標和穩健的控制鏈系統可增強臨床可靠性。先進的冷凍保存通訊協定、最佳化的冷凍保護劑化學成分和可控速率冷凍技術可提高長期細胞回收率，使儲存的細胞更可靠，可用於後續治療應用。區塊鏈和安全數位記錄正在試點應用，以保持與來源、知情同意以及母嬰健康數據的關聯，從而在滿足數據隱私監管要求的同時，促進相關調查。

市場成長將受法規結構和臨床證據的影響。隨著監管機構明確臍帶血衍生細胞治療產品的核准途徑，遵循GMP規範並提供符合監管要求文件的臍帶血庫將贏得醫療機構的青睞。臍帶血庫、生技公司和醫院之間的合作將建構轉化醫學流程，使儲存的臍帶血成為自體和異體移植療法的來源。在新興市場的地域擴張，以及本土認證體系和宣傳活動的支持下，將提升臍帶血的收集量。同時，提供公共、私人和指定捐贈選項的混合服務模式將為家庭和醫療系統創造靈活的價值提案。總而言之，臍帶血庫產業有望成為下一代細胞療法和個人化再生醫學策略的基礎。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章：全球臍帶血庫市場：依服務類型分類

• 市場分析、洞察與預測
• 收集/運輸
• 過程
• 分析
• 保持

第5章：全球臍帶血庫市場：依血庫分類

• 市場分析、洞察與預測
• 私人的
• 公共
• 混合

第6章 全球臍帶血庫市場：依組成部分分類

• 市場分析、洞察與預測
• 臍帶血
• 臍帶組織

第7章 全球臍帶血庫市場：依應用分類

• 市場分析、洞察與預測
• 癌症
• 遺傳性疾病
• 血液疾病
• 免疫力缺乏
• 代謝性疾病
• 其他用途

第8章：全球臍帶血庫市場：依最終用途分類

• 市場分析、洞察與預測
• 醫院
• 製藥和生物技術公司
• 學術研究機構

第9章 全球臍帶血庫市場：依地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第10章 競爭格局

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第11章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • Global Cord Blood Corporation
  • CBR Systems Inc
  • Cryo-Cell International
  • Cordlife Group Limited
  • AlphaCord LLC
  • CSG-BIO
  • California Cryobank Stem Cell Services LLC
  • Cord Blood Foundation（Smart Cells International）
  • Singapore Cord Blood Bank
  • FamiCord

The Cord Blood Banking Market size is expected to reach USD 67.07 Billion in 2034 from USD 34.00 Billion (2025) growing at a CAGR of 7.84% during 2026-2034.

Cord blood banking is entering a growth phase as cellular therapies and regenerative medicine expand beyond hematologic applications into broader immunotherapies and tissue repair. Cord blood is a rich source of hematopoietic stem and progenitor cells used in transplant medicine and an emerging reservoir for cell-based interventions such as engineered immune cells and regenerative constructs. As clinical trials validate novel indications-ranging from autoimmune disorders to neonatal brain injury-demand for high-quality, cryopreserved cord blood units and companion biobanking services will rise. Strategic differentiation will hinge on unit quality, processing methods, and the ability to provide linked clinical data that enhances translational utility.

Process innovation and standardization are key competitive levers. Closed automated collection and processing platforms reduce contamination risk and ensure higher viable cell yields; standardized viability assays, potency metrics, and robust chain-of-custody systems bolster clinical confidence. Advanced cryopreservation protocols, optimized cryoprotectant chemistries, and controlled-rate freezing technologies improve long-term cell recovery, making banked units more reliable for later therapeutic use. Blockchain and secure digital records are being piloted to maintain provenance, consent, and linkage to maternal and neonatal health data-facilitating research while meeting regulatory expectations around data privacy.

Market growth will be shaped by regulatory frameworks and clinical evidence. As regulatory agencies clarify pathways for cell therapy products derived from cord blood, banks that adhere to GMP-grade processing and provide regulatory-ready documentation will capture institutional demand. Collaboration between cord blood banks, biotech companies, and hospitals will unlock translational pipelines where stored units become sources for autologous and allogeneic therapies. Geographic expansion into emerging markets-supported by localized accreditation and education campaigns-will broaden collection volumes. In parallel, hybrid service models offering public, private, and directed donation options will create flexible value propositions for families and health systems. Collectively, the cord blood banking sector is positioned to underpin a new generation of cellular therapeutics and personalized regenerative strategies.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Service

• Collection & Transportation
• Processing
• Analysis
• Storage

By Bank

• Private
• Public
• Hybrid

By Component

• Cord Blood
• Cord Tissue

By Application

• Cancer
• Genetic Disorders
• Blood Disorders
• Immune Deficiencies
• Metabolic Disorders
• Other Applications

By End-use

• Hospitals
• Pharmaceutical & Biotechnology Companies
• Academic & Research Institutes

COMPANIES PROFILED

• Global Cord Blood Corporation, CBR Systems Inc, CryoCell International, Cordlife Group Limited, AlphaCord LLC, CSGBIO, California Cryobank Stem Cell Services LLC, Cord Blood Foundation Smart Cells International, Singapore Cord Blood Bank, FamiCord
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL CORD BLOOD BANKING MARKET: BY SERVICE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Service
• 4.2. Collection & Transportation Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Processing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Analysis Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Storage Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL CORD BLOOD BANKING MARKET: BY BANK 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Bank
• 5.2. Private Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Public Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Hybrid Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL CORD BLOOD BANKING MARKET: BY COMPONENT 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Component
• 6.2. Cord Blood Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Cord Tissue Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL CORD BLOOD BANKING MARKET: BY APPLICATION 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast Application
• 7.2. Cancer Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Genetic Disorders Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Blood Disorders Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.5. Immune Deficiencies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.6. Metabolic Disorders Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.7. Other Applications Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL CORD BLOOD BANKING MARKET: BY END-USE 2022-2034 (USD MN)

• 8.1. Market Analysis, Insights and Forecast End-use
• 8.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.3. Pharmaceutical & Biotechnology Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.4. Academic & Research Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 9. GLOBAL CORD BLOOD BANKING MARKET: BY REGION 2022-2034(USD MN)

• 9.1. Regional Outlook
• 9.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.2.1 By Service
  • 9.2.2 By Bank
  • 9.2.3 By Component
  • 9.2.4 By Application
  • 9.2.5 By End-use
  • 9.2.6 United States
  • 9.2.7 Canada
  • 9.2.8 Mexico
• 9.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.3.1 By Service
  • 9.3.2 By Bank
  • 9.3.3 By Component
  • 9.3.4 By Application
  • 9.3.5 By End-use
  • 9.3.6 United Kingdom
  • 9.3.7 France
  • 9.3.8 Germany
  • 9.3.9 Italy
  • 9.3.10 Russia
  • 9.3.11 Rest Of Europe
• 9.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.4.1 By Service
  • 9.4.2 By Bank
  • 9.4.3 By Component
  • 9.4.4 By Application
  • 9.4.5 By End-use
  • 9.4.6 India
  • 9.4.7 Japan
  • 9.4.8 South Korea
  • 9.4.9 Australia
  • 9.4.10 South East Asia
  • 9.4.11 Rest Of Asia Pacific
• 9.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.5.1 By Service
  • 9.5.2 By Bank
  • 9.5.3 By Component
  • 9.5.4 By Application
  • 9.5.5 By End-use
  • 9.5.6 Brazil
  • 9.5.7 Argentina
  • 9.5.8 Peru
  • 9.5.9 Chile
  • 9.5.10 South East Asia
  • 9.5.11 Rest of Latin America
• 9.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.6.1 By Service
  • 9.6.2 By Bank
  • 9.6.3 By Component
  • 9.6.4 By Application
  • 9.6.5 By End-use
  • 9.6.6 Saudi Arabia
  • 9.6.7 UAE
  • 9.6.8 Israel
  • 9.6.9 South Africa
  • 9.6.10 Rest of the Middle East And Africa

Chapter 10. COMPETITIVE LANDSCAPE

• 10.1. Recent Developments
• 10.2. Company Categorization
• 10.3. Supply Chain & Channel Partners (based on availability)
• 10.4. Market Share & Positioning Analysis (based on availability)
• 10.5. Vendor Landscape (based on availability)
• 10.6. Strategy Mapping

Chapter 11. COMPANY PROFILES OF GLOBAL CORD BLOOD BANKING INDUSTRY

• 11.1. Top Companies Market Share Analysis
• 11.2. Company Profiles
  • 11.2.1 Global Cord Blood Corporation
  • 11.2.2 CBR Systems Inc
  • 11.2.3 Cryo-Cell International
  • 11.2.4 Cordlife Group Limited
  • 11.2.5 AlphaCord LLC
  • 11.2.6 CSG-BIO
  • 11.2.7 California Cryobank Stem Cell Services LLC
  • 11.2.8 Cord Blood Foundation (Smart Cells International)
  • 11.2.9 Singapore Cord Blood Bank
  • 11.2.10 FamiCord